Literature DB >> 6646236

mRNA transcripts related to full-length endogenous retroviral DNA in human cells.

A B Rabson, P E Steele, C F Garon, M A Martin.   

Abstract

Mammalian cells contain multiple copies of endogenous type C retroviral DNA sequences. Among these sequences are complete, potentially infectious proviruses, proviral DNA that is expressed only in the form of viral antigens, retroviral segments that may contribute portions of envelope (env) genes during the generation of recombinant polytropic viruses, and many subgenomic viral DNA segments that may not be expressed at all. We have previously reported the identification and molecular cloning of type C retroviral sequences from human DNA and have shown that the partial nucleotide and deduced amino acid sequences of one of the clones obtained (lambda 51) are homologous to Moloney MuLV (MoMuLV) in the gag and pol regions. The lambda 51 clone as well as several others isolated from a human DNA library contained approximately 4.3 kilobases (kb) of retroviral sequences, were deleted in the env region, and were flanked by tandem repeats unlike the long terminal repeats (LTRs) typically found in proviral DNAs (P.E.S., in preparation). We describe here the characterization of a full-length human retroviral clone (lambda 4-1) containing LTR elements as well as a putative env region. DNA-RNA hybridization experiments reveal that human cells contain species of poly(A)+ RNA that anneal to segments of the full-length retroviral DNA clone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6646236     DOI: 10.1038/306604a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  26 in total

1.  Molecular analysis of several classes of endogenous feline leukemia virus elements.

Authors:  L H Soe; R W Shimizu; J R Landolph; P Roy-Burman
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

2.  Autonomous expression of RTVL-H endogenous retroviruslike elements in human cells.

Authors:  D A Wilkinson; J D Freeman; N L Goodchild; C A Kelleher; D L Mager
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses.

Authors:  A Shih; R Misra; M G Rush
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Human endogenous retrovirus K10 encodes a functional integrase.

Authors:  Y Kitamura; T Ayukawa; T Ishikawa; T Kanda; K Yoshiike
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Characterization of human endogenous retroviral envelope RNA transcripts.

Authors:  A B Rabson; Y Hamagishi; P E Steele; M Tykocinski; M A Martin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.

Authors:  S J Arrigo; S Weitsman; J D Rosenblatt; I S Chen
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin.

Authors:  A M Schulte; A Wellstein
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Antigens related to the major internal protein, p27, of a psoriasis associated retrovirus-like particle are expressed in patients with chronic arthritis.

Authors:  E Rødahl; O J Iversen
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

9.  Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences.

Authors:  N Kato; S Pfeifer-Ohlsson; M Kato; E Larsson; J Rydnert; R Ohlsson; M Cohen
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

10.  Identification of a retrovirus-like repetitive element in human DNA.

Authors:  D L Mager; P S Henthorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.